aod9604 wada prohibited list status 2025 WADA's Comes into Force BPC-157 FDA Approval Status 2026:

Furthermore, a legitimate AOD 9604 protocol involves baseline labs, a titration plan, and clinical follow-ups

As with any emerging pharmacological agent, the establishment of a safe and effective dosage for clinical use necessitates thorough and rigorous clinical trials

The primary preclinical evidence comes from mouse studies showing reduced body weight and adipose mass in diet-induced obese mice (2018), improved grip strength in aged mice (2024), and beneficial microbiome changes when combined with caloric restriction (2022)

Yet, the mechanisms they employ have complimenting approaches in managing metabolic health

[DOI] [PMC free article] [PubMed] [Google Scholar] 313.Berven, H